Skip to content

Clinical trials

Phase 4 Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 4 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20091
20101
20112
20122
20131
20143
20161
20201
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status5
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Betta Pharmaceuticals Co., Ltd.3
Nottingham University Hospitals NHS Trust3
Astellas Pharma Global Development, Inc.1
Celgene1
Centre Oscar Lambret1
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives1
Hvidovre University Hospital1
Mayo Clinic1
The Catholic University of Korea1
Tian Xie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma15
Anemia3
Carcinoma2
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Postoperative Complications2
Stomach Neoplasms2
Breast Neoplasms1
Carcinoma, Large Cell1
Carcinoma, Squamous Cell1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.